指南与共识消化、代谢与肾脏急症

肿瘤替代支付模式的结果测量:实践考量与建议

Outcome measures for oncology alternative payment models: practical considerations and recommendations.
指南 / 共识 · Am J Manag Care · 2019-12-01
一句话结论本文提出34项基于结果的肿瘤质量测量指标,分为5个领域,供未来肿瘤替代支付模式参考。

本文通过聚焦文献综述、内容分析和质量测量综合,研究了7个肿瘤质量评估框架共142项质量指标,重点聚焦基于结果的质量测量。作者提出34项基于结果的肿瘤质量测量指标,分为临床照护、安全性、照护协调、患者与照护者体验、人群健康与预防5个领域。作者认为肿瘤替代支付模式中应酌情考虑通用和适应症特异的结果测量,但采用基于结果的测量需解决风险调整和数据质量保证等多重挑战。

要点

  • 作者提出34项基于结果的肿瘤质量测量指标,分为临床照护、安全性、照护协调、患者与照护者体验、人群健康与预防5个领域。
  • 临床照护领域指标包括医院和急诊就诊、治疗有效性、死亡率等。
  • 安全性领域指标包括感染、医院不良事件等。
  • 作者认为肿瘤替代支付模式中应酌情考虑通用和适应症特异的结果测量。
  • 采用基于结果的测量需解决从风险调整到数据质量保证等多重挑战。

研究设计与关键结果

  • 研究设计为聚焦文献综述、内容分析和质量测量综合与分类。
  • 研究了7个肿瘤质量评估框架,涵盖142项质量指标。
  • 使用Center for Medicare and Medicaid Innovation APM工具包综合建议,聚焦结果测量。
  • 提出34项基于结果的肿瘤质量测量指标,分为临床照护、安全性、照护协调、患者与照护者体验、人群健康与预防5个领域。
  • 临床照护领域举例包括医院和急诊就诊、治疗有效性、死亡率;安全性领域举例包括感染、医院不良事件。
  • 作者认为肿瘤替代支付模式中应酌情考虑通用和适应症特异的结果测量。
  • 采用基于结果的测量将需要解决从风险调整到数据质量保证的多重挑战。

证据类型、等级与局限

  • 证据类型:聚焦文献综述、内容分析和质量测量综合与分类。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为肿瘤照护将从更严格的质量评估方法中获益。
  • 作者认为肿瘤替代支付模式的成功将需要一套对患者、提供者和支付方均相关的稳健质量测量。
  • 作者认为肿瘤替代支付模式中应酌情考虑通用和适应症特异的结果测量。
  • 采用基于结果的测量将需要解决从风险调整到数据质量保证的多重挑战。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「适用人群与场景」「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: This paper aims to synthesize existing scholarship on quality measures in oncology, with a specific focus on outcome-based quality measures, which are often underutilized. We also present a set of "core outcome measures" that may be considered in future oncology alternative payment models (APMs).

STUDY DESIGN: Our research consists of a focused literature review, content analysis, and quality measure synthesis and categorization.

METHODS: We conducted a focused literature review to generate key evidence on quality measures in oncology. We studied 7 oncology quality assessment frameworks, encompassing 142 quality metrics, and synthesized recommendations using the Center for Medicare and Medicaid Innovation APM toolkit, focusing on outcome measures.

RESULTS: We present 34 outcome-based oncology quality measures for consideration, which are classified into 5 domains: clinical care (eg, hospital and emergency department visits, treatment effectiveness, mortality), safety (eg, infections, hospital adverse events), care coordination (for hospital and hospice care), patient and caregiver experience, and population health and prevention. Both general and indication-specific outcome measures should be considered in oncology APMs, as appropriate. Utilizing outcome-based measures will require addressing multiple challenges, ranging from risk adjustment to data quality assurance.

CONCLUSIONS: Oncology care will benefit from a more rigorous approach to quality assessment. The success of oncology APMs will require a robust set of quality measures that are relevant to patients, providers, and payers.

来源:Am J Manag Care,查看原文。版权归原作者所有。

参考来源

  1. Hlávka JP, Lin PJ, Neumann PJ, et al. Outcome measures for oncology alternative payment models: practical considerations and recommendations. Am J Manag Care. 2019. PMID: 31860235

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。